Clinical Trial Supply & Logistics For Pharmaceutical Market: By Service Type, By Phase, By Therapeutic Area, and Geography

Clinical Trial Supply & Logistics For Pharmaceutical Market Size, Share, Growth, Trends, and Global Industry Analysis: By Service Type (Manufacturing, Packaging & Labeling, and Distribution & Storage), By Phase (Phase I, Phase II, Phase III, and Phase IV), By Therapeutic Area (Oncology, CNS, Cardiovascular, Infectious Diseases, and Others), and Region

Clinical Trial Supply and Logistics for Pharmaceutical Market size was valued at approximately US$ 15,629.7 million in 2023 and is projected to grow at a CAGR of 7.1% from 2024 to 2030. This market encompasses services related to the manufacturing, packaging, labeling, storage, and distribution of clinical trial materials for pharmaceutical companies. The growth is primarily driven by the increasing number of clinical trials, rising complexity of trial designs, and the globalization of clinical research. According to ClinicalTrials.gov, as of May 2023, there were over 430,000 registered studies across 221 countries, indicating the vast scale of clinical trial activities worldwide.

The COVID-19 pandemic has further accelerated market growth by highlighting the importance of efficient supply chain management in clinical trials, with many companies adopting decentralized trial models. Additionally, the increasing focus on personalized medicine and rare diseases is contributing to the demand for specialized logistics services. The Tufts Center for the Study of Drug Development reported that rare disease trials grew by 88% between 2011 and 2020, requiring more complex supply chain solutions. However, challenges such as stringent regulatory requirements, temperature control issues, and the need for real-time tracking of clinical supplies may hinder market growth to some extent. The market is also influenced by technological advancements, with the integration of blockchain and IoT devices for enhanced traceability and temperature monitoring becoming increasingly prevalent.

Clinical Trial Supply and Logistics for Pharmaceutical Market Key Developments

  • In March 2023, Thermo Fisher Scientific expanded its clinical supply chain services with a new facility in Germany, enhancing its European distribution capabilities and introducing automated storage and retrieval systems.
  • In August 2022, Marken, a critical part of UPS Healthcare, reached an agreement to purchase the medical courier business of Cedra Express, a New Zealand-based transportation and logistics provider serving the life science and pharmaceutical segment. This acquisition will enhance Marken’s presence and capabilities as a healthcare logistics provider in the region.

Clinical Trial Supply & Logistics For Pharmaceutical Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

7.1%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Clinical Trial Supply & Logistics For Pharmaceutical Market Dynamics

The clinical trial supply and logistics for pharmaceutical market is witnessing significant growth in the packaging and labeling segment due to the increasing complexity of clinical trials and the need for customized packaging solutions. The rise of adaptive trial designs and patient-centric approaches has led to a demand for flexible packaging that can accommodate mid-study changes.

According to a survey by the Tufts Center for the Study of Drug Development, 94% of pharmaceutical companies reported using adaptive trial designs in some of their clinical studies. This trend is driving innovation in packaging technologies, such as smart labels and temperature-sensitive packaging materials. The integration of RFID technology in clinical trial packaging has improved inventory management and reduced medication errors. The cold chain logistics segment is also experiencing substantial growth, driven by the increasing number of temperature-sensitive biopharmaceuticals in clinical trials. Biopharma products now account for over 40% of the pharmaceutical industry pipeline, as reported by the Pharmaceutical Research and Manufacturers of America (PhRMA) in 2022. This shift towards biologics has intensified the need for sophisticated cold chain solutions, including real-time temperature monitoring and specialized storage facilities.

Clinical Trial Supply & Logistics For Pharmaceutical Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 15,629.7 million

Market CAGR

7.1%

By Service Type

  • Manufacturing
  • Packaging and Labeling
  • Distribution and Storage

By Phase

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By Therapeutic Area

  • Oncology
  • CNS
  • Cardiovascular
  • Infectious Diseases
  • Others

By Region

  • North America
  • Europe
  • The Asia Pacific
  • Latin America
  • MEA

Key Features of the Report

  • The clinical trial supply & logistics for pharmaceutical market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030).
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario.
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market

Download Free Sample Report

Frequently Asked Questions

Clinical trial supply and logistics for pharmaceutical market size was valued at US$ 15,629.7 million in 2023 and is projected to grow at a CAGR of 7.1%.

The leading players in the market include Catalent, Inc., ThermoFisher Scientific Inc., Almac Group, Parexel International Corporation, and UPS Healthcare, among others.

The growth is driven by increasing clinical trials, growing complexity of trial designs, globalization of clinical research, rising focus on personalized medicine, and the need for specialized logistics for biologics and rare disease trials.

The restraints include stringent regulatory requirements, challenges in maintaining temperature control, high costs associated with specialized logistics, and the need for real-time tracking and data management of clinical supplies.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Clinical Trial Supply & Logistics For Pharmaceutical Market Introduction 
2.1.Global Clinical Trial Supply & Logistics For Pharmaceutical Market  - Taxonomy
2.2.Global Clinical Trial Supply & Logistics For Pharmaceutical Market  - Definitions
2.2.1. Service Type
2.2.2.Phase
2.2.3.Therapeutic Area
2.2.4.Region
3.Global Clinical Trial Supply & Logistics For Pharmaceutical Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Clinical Trial Supply & Logistics For Pharmaceutical Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Clinical Trial Supply & Logistics For Pharmaceutical Market  By  Service Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Manufacturing
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Packaging and Labeling
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Distribution and Storage
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Clinical Trial Supply & Logistics For Pharmaceutical Market  By Phase, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Phase I
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Phase II
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Phase III
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Phase IV
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7.Global Clinical Trial Supply & Logistics For Pharmaceutical Market  By Therapeutic Area, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Oncology
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. CNS
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Cardiovascular
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Infectious Diseases
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Others
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.Global Clinical Trial Supply & Logistics For Pharmaceutical Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Clinical Trial Supply & Logistics For Pharmaceutical Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1.  Service Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Manufacturing
9.1.2.Packaging and Labeling
9.1.3.Distribution and Storage
9.2.  Phase Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Phase I
9.2.2.Phase II
9.2.3.Phase III
9.2.4.Phase IV
9.3.  Therapeutic Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Oncology
9.3.2.CNS
9.3.3.Cardiovascular
9.3.4.Infectious Diseases
9.3.5.Others
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Clinical Trial Supply & Logistics For Pharmaceutical Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1.  Service Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Manufacturing
10.1.2.Packaging and Labeling
10.1.3.Distribution and Storage
10.2.  Phase Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Phase I
10.2.2.Phase II
10.2.3.Phase III
10.2.4.Phase IV
10.3.  Therapeutic Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Oncology
10.3.2.CNS
10.3.3.Cardiovascular
10.3.4.Infectious Diseases
10.3.5.Others
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Clinical Trial Supply & Logistics For Pharmaceutical Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1.  Service Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Manufacturing
11.1.2.Packaging and Labeling
11.1.3.Distribution and Storage
11.2.  Phase Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Phase I
11.2.2.Phase II
11.2.3.Phase III
11.2.4.Phase IV
11.3.  Therapeutic Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Oncology
11.3.2.CNS
11.3.3.Cardiovascular
11.3.4.Infectious Diseases
11.3.5.Others
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Clinical Trial Supply & Logistics For Pharmaceutical Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1.  Service Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Manufacturing
12.1.2.Packaging and Labeling
12.1.3.Distribution and Storage
12.2.  Phase Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Phase I
12.2.2.Phase II
12.2.3.Phase III
12.2.4.Phase IV
12.3.  Therapeutic Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Oncology
12.3.2.CNS
12.3.3.Cardiovascular
12.3.4.Infectious Diseases
12.3.5.Others
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Clinical Trial Supply & Logistics For Pharmaceutical Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1.  Service Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Manufacturing
13.1.2.Packaging and Labeling
13.1.3.Distribution and Storage
13.2.  Phase Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Phase I
13.2.2.Phase II
13.2.3.Phase III
13.2.4.Phase IV
13.3.  Therapeutic Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Oncology
13.3.2.CNS
13.3.3.Cardiovascular
13.3.4.Infectious Diseases
13.3.5.Others
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Catalent, Inc.
14.2.2.Thermo Fisher Scientific Inc.
14.2.3.Almac Group
14.2.4.Parexel International Corporation
14.2.5.UPS Healthcare
14.2.6.Marken (a UPS company)
14.2.7.PCI Pharma Services
14.2.8.Sharp
14.2.9.Biocair
14.2.10.World Courier
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Catalent, Inc.
  • Thermo Fisher Scientific Inc.
  • Almac Group
  • Parexel International Corporation
  • UPS Healthcare
  • Marken (a UPS company)
  • PCI Pharma Services
  • Sharp
  • Biocair
  • World Courier (an AmerisourceBergen company)

Related Industry Reports